Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 2/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.31 |
| ▸ | CHIT1 | Q13231 | 1/20 | 0.31 |
| ▸ | BRAF | P15056 | 2/20 | 0.30 |
| ▸ | FBP1 | P09467 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7873476 | 0.88 | LMNA (0.35) | FBP1 | |
| SCHEMBL7879845 | 0.88 | MAPK8 (0.34) | MAPK8MAPK10BRAF | |
| SCHEMBL7877749 | 0.85 | MEN1 (0.38) | CYP1A2CYP2C9CYP2C19KDRCHIT1 | |
| SCHEMBL7882210 | 0.85 | BRAF (0.33) | KDRBRAFFBP1 | |
| SCHEMBL7873833 | 0.85 | MEN1 (0.38) | CYP2C9CYP2C19CHIT1FBP1 | |
| SCHEMBL7885028 | 0.84 | MAPK8 (0.36) | MAPK8MAPK10CHIT1BRAF | |
| SCHEMBL7884525 | 0.84 | APEX1 (0.35) | KDRERBB2PTK6CHIT1 | |
| SCHEMBL7879751 | 0.83 | RHEB (0.32) | MAPK10KDRERBB2PTK6CHIT1 | |
| SCHEMBL7873258 | 0.83 | CYP1A2 (0.32) | MAPK8MAPK10CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7884795 | 0.83 | SIRT2 (0.37) | CYP1A2CYP2C9CYP2C19FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |